Van Hemelrijck Mieke, Lewison Grant, Fox Louis, Vanderpuye Verna Dnk, Murillo Raúl, Booth Chris M, Canfell Karen, Pramesh C S, Sullivan Richard, Mukherij Deborah
King's College London, Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), London SE1 9RT, UK.
King's College London, Faculty of Life Sciences and Medicine, Institute of Cancer Policy, London SE1 9RT, UK.
Ecancermedicalscience. 2021 Jul 7;15:1264. doi: 10.3332/ecancer.2021.1264. eCollection 2021.
Patients with cancer across the world have been impacted by the COVID-19 pandemic due to increased risk of infection and disruption to cancer diagnosis and treatment. Widening of healthcare disparities is expected as the gap between health systems with and without adequate resources to mitigate the pandemic become more apparent. We undertook a bibliometric analysis of research related to cancer and COVID-19 to understand (1) the type of research that has been conducted (e.g. patients, services and systems) and (2) whether the pandemic has impacted the state of global cancer research as measured by research outputs to date.
An existing filter for cancer research consisting of title words and the names of specialist cancer journals was used to identify cancer and COVID-19 related articles and reviews in the Web of Science (©Clarivate Analytics) between January 2019 and February 2021.
One thousand five hundred and forty-five publications were identified. The majority (57%) were reviews, opinion pieces or concerned with modelling impact of delays to diagnosis and treatment. The main research domains focused on managing or estimating COVID-19 risk to cancer patients accounting for 384 papers (25%). High Income countries contributed the largest volume ( = 1,115; 72%), compared to Upper Middle ( = 302; 20%), Lower Middle ( = 122; 8%) and Low Income countries ( = 2.4; 0.2%). No evidence of a reduction in global cancer research output was observed in 2020.
We observed a shift in research focus rather than a decline in absolute output. However, there is variation based on national income and collaborations are minimal. There has been a focus on pan-cancer studies rather than cancer site-specific studies. Strengthening global multidisciplinary research partnerships with teams from diverse backgrounds with regard to gender, clinical expertise and resource setting is essential to prevent the widening of cancer inequalities.
由于感染风险增加以及癌症诊断和治疗受到干扰,全球癌症患者受到了新冠疫情的影响。随着有无足够资源来缓解疫情的卫生系统之间的差距变得更加明显,预计医疗保健差距将会扩大。我们对与癌症和新冠疫情相关的研究进行了文献计量分析,以了解:(1)已开展的研究类型(例如患者、服务和系统);(2)就迄今为止的研究产出而言,疫情是否影响了全球癌症研究状况。
使用一个现有的癌症研究筛选器,该筛选器由标题词和专业癌症期刊名称组成,用于识别2019年1月至2021年2月期间科学网(©科睿唯安分析公司)中与癌症和新冠疫情相关的文章及综述。
共识别出1545篇出版物。其中大多数(57%)是综述、观点文章或与诊断和治疗延迟的建模影响有关。主要研究领域集中在管理或评估新冠疫情对癌症患者的风险,占384篇论文(25%)。高收入国家的贡献量最大(=1115;72%),相比之下,中高收入国家(=302;20%)、中低收入国家(=122;8%)和低收入国家(=2.4;0.2%)。2020年未观察到全球癌症研究产出减少的证据。
我们观察到研究重点发生了转变,而非绝对产出下降。然而,存在基于国民收入的差异,且合作极少。研究重点一直是泛癌研究,而非特定癌症部位的研究。加强与来自不同性别、临床专业知识和资源背景的团队的全球多学科研究伙伴关系,对于防止癌症不平等加剧至关重要。